Die Übersetzung dieser Seite ist experimentell und in Entwicklung. Wir freuen uns über Ihr !

Conduent Zukünftiges Wachstum

Future Kriterienprüfungen 2/6

ConduentDer Gewinn des Unternehmens wird voraussichtlich um 15.3% pro Jahr sinken, während der Jahresumsatz voraussichtlich um 2.9% pro Jahr wachsen wird. Der Gewinn pro Aktie wird voraussichtlich sinken um 14.7% pro Jahr.

Wichtige Informationen

-14.6%

Wachstumsrate der Gewinne

-14.4%

EPS-Wachstumsrate

Professional Services Gewinnwachstum	18.5%
Wachstumsrate der Einnahmen	2.3%
Zukünftige Eigenkapitalrendite	n/a
Analystenabdeckung	Low
Zuletzt aktualisiert	30 May 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Recent updates

Conduent: Still Maintaining The Long Thesis, Although Some Concerns Over Renewal Momentum

May 10

Conduent (NASDAQ:CNDT) Might Have The Makings Of A Multi-Bagger

Apr 07

What Percentage Of Conduent Incorporated (NASDAQ:CNDT) Shares Do Insiders Own?

Mar 17

Clifford Skelton Is The President of Conduent Incorporated (NASDAQ:CNDT) And They Just Picked Up 1.1% More Shares

Feb 24

Gewinn- und Umsatzwachstumsprognosen

NasdaqGS:CNDT - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (USD Millions)
Datum	Umsatz	Gewinne	Freier Cashflow	Bargeld aus operativen Tätigkeiten	Durchschn. Anz. Analysten
12/31/2026	3,948	-227	333	460	1
12/31/2025	3,279	-152	322	294	2
12/31/2024	3,456	321	399	119	3
3/31/2024	3,721	-201	-28	64	N/A
12/31/2023	3,722	-306	-4	89	N/A
9/30/2023	3,755	-645	-89	18	N/A
6/30/2023	3,800	-341	15	127	N/A
3/31/2023	3,813	-334	-4	121	N/A
12/31/2022	3,858	-192	-9	144	N/A
9/30/2022	3,920	101	22	178	N/A
6/30/2022	3,981	97	-24	135	N/A
3/31/2022	4,079	109	89	256	N/A
12/31/2021	4,140	-38	96	243	N/A
9/30/2021	4,147	-9	185	330	N/A
6/30/2021	4,150	-27	232	382	N/A
3/31/2021	4,140	-90	206	351	N/A
12/31/2020	4,163	-128	22	161	N/A
9/30/2020	4,207	-698	185	337	N/A
6/30/2020	4,264	-707	86	248	N/A
3/31/2020	4,360	-1,685	-180	-11	N/A
12/31/2019	4,467	-1,944	-83	132	N/A
9/30/2019	4,650	-1,503	-195	37	N/A
6/30/2019	4,856	-1,724	-258	-11	N/A
3/31/2019	5,131	-684	17	272	N/A
12/31/2018	5,393	-426	59	283	N/A
9/30/2018	5,604	-78	67	266	N/A
6/30/2018	5,780	142	230	400	N/A
3/31/2018	5,889	127	223	369	N/A
12/31/2017	6,022	167	N/A	300	N/A
9/30/2017	6,043	-989	N/A	210	N/A
6/30/2017	6,159	-969	N/A	246	N/A
3/31/2017	6,276	-972	N/A	118	N/A
12/31/2016	6,408	-983	N/A	95	N/A
9/30/2016	6,624	-23	N/A	450	N/A
6/30/2016	6,599	-260	N/A	438	N/A
3/31/2016	6,669	-353	N/A	517	N/A
12/31/2015	6,662	-336	N/A	493	N/A
12/31/2014	6,938	34	N/A	665	N/A
12/31/2013	6,879	135	N/A	379	N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: CNDTFür die nächsten 3 Jahre wird ein Rückgang der Gewinne prognostiziert (-15.3% pro Jahr).

Ertrag vs. Markt: CNDT wird in den nächsten 3 Jahren voraussichtlich rentabel werden, was als überdurchschnittliches Marktwachstum angesehen wird.

Hohe Wachstumserträge: CNDT wird voraussichtlich in den nächsten 3 Jahren rentabel werden.

Einnahmen vs. Markt: CNDTDie Einnahmen des Unternehmens (2.9% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt US (8.4% pro Jahr).

Hohe Wachstumseinnahmen: CNDTDie Einnahmen des Unternehmens (2.9% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: Unzureichende Daten, um festzustellen, ob die Eigenkapitalrendite von CNDT in 3 Jahren voraussichtlich hoch sein wird

Conduent Zukünftiges Wachstum

Future Kriterienprüfungen 2/6

Wichtige Informationen

Jüngste Aktualisierungen zum künftigen Wachstum

Conduent Incorporated Provides Earnings Guidance for the Full Year 2024

Consensus EPS estimates upgraded to US$0.20 loss

Price target decreased to US$3.75

Consensus forecasts updated

Price target decreased to US$6.50

Forecast breakeven date pushed back to 2023

Recent updates

Is Conduent (NASDAQ:CNDT) A Risky Investment?

MedRisk, LLC agreed to acquire Conduent Casualty Claims Solutions LLC from Conduent Incorporated (NasdaqGS:CNDT) for approximately $240 million.

MedRisk, LLC agreed to acquire Conduent Casualty Claims Solutions LLC from Conduent Incorporated (NasdaqGS:CNDT) for approximately $240 million.

Conduent Incorporated Provides Earnings Guidance for the Full Year 2024

First quarter 2024 earnings released: EPS: US$0.46 (vs US$0.037 loss in 1Q 2023)

Conduent Incorporated to Report Q1, 2024 Results on May 01, 2024

Conduent Incorporated, Annual General Meeting, May 17, 2024

New minor risk - Profitability

Returns On Capital Are Showing Encouraging Signs At Conduent (NASDAQ:CNDT)

Full year 2023 earnings: EPS exceeds analyst expectations

Conduent Incorporated to Report Q4, 2023 Results on Feb 14, 2024

Is Conduent (NASDAQ:CNDT) Using Too Much Debt?

Conduent Transportation Develops New Software Platform to Transform Ticket Vending Machines First Used by Trenord in Italy

Conduent Incorporated Announces Goodwill Impairment for Three Months Ended September 30, 2023

Third quarter 2023 earnings released

New major risk - Revenue and earnings growth

Is Conduent (NASDAQ:CNDT) A Risky Investment?

Conduent Incorporated Announces its Latest Finance, Accounting and Procurement Software Solution, Fastcap Finance Analytics

Conduent Incorporated to Report Q3, 2023 Results on Nov 01, 2023

Conduent (NASDAQ:CNDT) Is Experiencing Growth In Returns On Capital

Consensus EPS estimates upgraded to US$0.20 loss

Insufficient new directors

Second quarter 2023 earnings released: US$0.04 loss per share (vs US$0.014 loss in 2Q 2022)

Conduent Incorporated to Offer U.S. Federal Reserve’s FedNow? Service for Instant Payments

Conduent Incorporated Presents Financing Solutions to Support Lenders at NAF Association Non-Prime Auto Financing Conference

Conduent Incorporated, Annual General Meeting, May 24, 2023

Conduent Incorporated Announces A New Provider Data Management Solution

Conduent (NASDAQ:CNDT) Is Looking To Continue Growing Its Returns On Capital

Conduent Incorporated (NasdaqGS:CNDT) announces an Equity Buyback for $75 million worth of its shares.

President recently bought US$100k worth of stock

First quarter 2023 earnings released: US$0.04 loss per share (vs US$0.62 profit in 1Q 2022)

These 4 Measures Indicate That Conduent (NASDAQ:CNDT) Is Using Debt Extensively

Full year 2022 earnings released: US$0.89 loss per share (vs US$0.18 loss in FY 2021)

Conduent Incorporated Reports Impairment Charges for the Fourth Quarter Ended December 31, 2022

Conduent (NASDAQ:CNDT) Is Experiencing Growth In Returns On Capital

Conduent Incorporated to Report Q4, 2022 Results on Feb 14, 2023

Conduent Launches IntelliHealth Module for Healthcare Provider Engagement

We Think Conduent (NASDAQ:CNDT) Can Stay On Top Of Its Debt

Conduent Incorporated Releases Enhanced Viewpoint eDiscovery 7.5 Platform

Price target decreased to US$3.75

Conduent Introduces Benepath® Suite of Solutions to Assist States with Eligibility and Enrollment for Medicaid, Snap and Other Benefit Programs

Third quarter 2022 earnings released: EPS: US$0.06 (vs US$0.042 in 3Q 2021)

Conduent Incorporated to Report Q3, 2022 Results on Nov 01, 2022

Conduent (NASDAQ:CNDT) Is Looking To Continue Growing Its Returns On Capital

Conduent Incorporated Deeply Engages Disease Surveillance for the Past 20 Years with the Development of the Maven(R) Disease Surveillance & Outbreak Management Platform

We Think Conduent (NASDAQ:CNDT) Is Taking Some Risk With Its Debt

President recently bought US$202k worth of stock

Second quarter 2022 earnings: Revenues in line with analyst expectations

Conduent Q2 2022 Earnings Preview

Conduent (NASDAQ:CNDT) Is Doing The Right Things To Multiply Its Share Price

Conduent Incorporated to Report Q2, 2022 Results on Aug 02, 2022

Investor sentiment deteriorated over the past week

Conduent (NASDAQ:CNDT) Strong Profits May Be Masking Some Underlying Issues

Consensus forecasts updated

Conduent Incorporated Showcases its Legal Spend and Contract Analytics Tools at CLOC Global Institute

President recently bought US$100k worth of stock

First quarter 2022 earnings: EPS exceeds analyst expectations

Conduent Incorporated Announces Two New Enhancements to its Highly Configurable Strataware Medical Bill Review Platform

Price target decreased to US$6.50

High number of new directors

Conduent Incorporated to Report Q1, 2022 Results on May 03, 2022

Conduent: Solid Margins, A Potential Spin-Off, And Undervalued

Conduent Incorporated, Annual General Meeting, May 25, 2022

Executive VP recently bought US$100k worth of stock

Here's Why Conduent (NASDAQ:CNDT) Has A Meaningful Debt Burden

Forecast breakeven date pushed back to 2023

Full year 2021 earnings: EPS misses analyst expectations

Conduent Incorporated Provides Earnings Guidance for the Fiscal Year 2023

Conduent Incorporated to Report Q4, 2021 Results on Feb 16, 2022